Cara Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cara Therapeutics Inc
TickerCARA
CIK #0001346830
CUSIP140755109
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Parrott Drive, Shelton, CT 06484
Source [EDGAR]
CIK Filing 2011 - 2025
[0001346830] 10-K
[0001346830] 10-Q
[0001346830] 3
[0001346830] 4
[0001346830] 8-K
[0001346830] D
[0001346830] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Bain Capital Life Sciences Opportunities III LP Cara Therapeutics Inc [2022-11-18] 5.0
Vanguard Group Inc Cara Therapeutics Inc [2022-02-09] 5.67
First Manhattan Co Cara Therapeutics Inc [2021-02-16] 6.45
Vifor International Ltd Cara Therapeutics Inc [2020-10-23] 8.3
Price T Rowe Associates Inc /MD/ Cara Therapeutics Inc [2019-02-14] 6.1
State Street Corp Cara Therapeutics Inc [2019-02-14] 5.4
State Street Corp Cara Therapeutics Inc [2018-02-14] 6.07
BlackRock Inc Cara Therapeutics Inc [2018-02-01] 6.8
BlackRock Inc Cara Therapeutics Inc [2016-01-28] 5.3
Point72 Asset Management LP Cara Therapeutics Inc [2015-12-07] 2.0
Ridgeback Capital Investments LP Cara Therapeutics Inc [2015-04-20] 7.9
Esperante BV Cara Therapeutics Inc [2015-02-17] 6.8
Devon Park BioVentures LP Cara Therapeutics Inc [2015-02-13] 5.06
Devon Park BioVentures LP Cara Therapeutics Inc [2015-02-13] 5.06
Devon Park BioVentures LP Cara Therapeutics Inc [2015-02-13] 5.06
FMR LLC Cara Therapeutics Inc [2015-02-13] 0.0
MVM International Life Sciences Fund No 1 L P Cara Therapeutics Inc [2015-02-09] 5.7
Rho Ventures VI LP Cara Therapeutics Inc [2015-01-29] 11.7
ABV LLC Cara Therapeutics Inc [2014-02-10] 4.3
Flynn James E Cara Therapeutics Inc [2014-02-07] 1.55
Form 3/4/5 Filer 2011 - 2025
Cara Therapeutics, Inc.
Shiff Susan Ph.D.
Ives Jeffrey L.
von Moltke Lisa
Bains Harrison M Jr
Vogelbaum Martin
Posner Christopher
Goncalves Joana
Terrillion Scott
Menzaghi Frederique Ph.D.
Maynard Ryan D
Makara Richard
Reilly Thomas Charles
Vifor Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor (International) Ltd
Chalmers Derek T
Mohindru Mani
Stauffer Joseph William
Schoell Josef
Slagel Dean
RMV VI LLC
Kairouz Habib
Leschly Mark
Ruch Joshua
Rho Capital Partners LLC
RHO Ventures VI LP
Lewis Michael E
Medve Robert
Moller Charles Ph.D.
Champsi Farah
Hurwitz Edward
Penhoet Edward
Alta Biopharma Partners III LP
Alta Biopharma Partners III GmbH & Co Beteiligungs KG
Alta Biopharma Management III LLC
Alta Embarcadero Biopharma Partners III LLC
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 7,482,488.0 7,600,482.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,053,355.0
Bain Capital Life Sciences Investors, LLC [2023-03-31] SOLE 2,204,449.0 2,204,449.0
Farallon Capital Management LLC [2023-03-31] OTR 1,995,370.0 1,995,370.0
State Street Corp [2023-03-31] DFND 1,805,522.0 1,902,942.0
Disciplined Growth Investors Inc /MN [2023-03-31] SOLE 1,732,375.0 1,732,375.0
Kingdon Capital Management LLC [2023-03-31] DFND 1,233,000.0 1,233,000.0
Chescapmanager LLC [2023-03-31] DFND 1,160,392.0 1,160,392.0
Geode Capital Management LLC [2023-03-31] DFND 892,319.0 892,319.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 801,160.0 873,534.0
Bank of America Corp /DE/ [2023-03-31] DFND 8,489.0 760,850.0
Northern Trust Corp [2023-03-31] DFND 21,928.0 704,393.0
Pinnacle Associates Ltd [2023-03-31] SOLE 678,338.0 679,413.0
C WorldWide Group Holding A/S [2023-03-31] DFND 583,460.0 583,460.0
Citadel Advisors LLC [2023-03-31] DFND 560,571.0 560,571.0
Clearbridge Investments LLC [2023-03-31] SOLE 437,710.0 485,535.0
Bank of New York Mellon Corp [2023-03-31] DFND 371,363.0 403,402.0
Morgan Stanley [2023-03-31] DFND 352,849.0 380,020.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 335,872.0 335,872.0
Goldman Sachs Group Inc [2023-03-31] DFND 286,719.0 303,625.0
Principal Financial Group Inc [2023-03-31] DFND 280,872.0 280,872.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 244,181.0
ExodusPoint Capital Management LP [2023-03-31] SOLE 213,644.0 213,644.0
Jupiter Asset Management Ltd [2023-03-31] DFND 202,341.0 202,341.0
Royce & Associates LP [2023-03-31] SOLE 202,300.0 202,300.0
Squarepoint Ops LLC [2023-03-31] DFND 0.0 195,818.0
Invesco Ltd. [2023-03-31] DFND 0.0 190,630.0
Federated Hermes Inc [2023-03-31] DFND 184,349.0 184,349.0
LPL Financial LLC [2023-03-31] SOLE 9,702.0 174,868.0
Two Sigma Investments LP [2023-03-31] SOLE 163,736.0 163,736.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com